BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4712655)

  • 1. Stoichiometry of the drug-nicotinic receptor interaction.
    Parker RB; Goldfine C
    J Pharmacol Exp Ther; 1973 Jun; 185(3):649-52. PubMed ID: 4712655
    [No Abstract]   [Full Text] [Related]  

  • 2. Ion exchange processes at the neuromuscular junction of voluntary muscle.
    Taylor DB; Steinborn J; Lu TC
    J Pharmacol Exp Ther; 1970 Oct; 175(1):213-27. PubMed ID: 5471448
    [No Abstract]   [Full Text] [Related]  

  • 3. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission.
    Lu TC
    J Pharmacol Exp Ther; 1970 Sep; 174(3):560-6. PubMed ID: 4247938
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of inorganic ions in ion exchange processes at the cholinergic receptor of voluntary muscle.
    Taylor DB
    J Pharmacol Exp Ther; 1973 Sep; 186(3):537-51. PubMed ID: 4728334
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylcholine receptor. Responses to drug binding.
    Maelicke A; Fulpius BW; Klett RP; Reich E
    J Biol Chem; 1977 Jul; 252(14):4811-30. PubMed ID: 873918
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat.
    Katz RL; Eakins KE
    J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular theory about the mechanism of action of curare compounds].
    Waser PG
    Anaesthesist; 1971 Jan; 20(1):23-9. PubMed ID: 4251063
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drug-receptor dissociation constants at the mammalian neuromuscular junction in the presence and absence of halothane.
    Waud BE; Cheng MC; Waud DR
    J Pharmacol Exp Ther; 1973 Oct; 187(1):40-6. PubMed ID: 4746332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extraction from electric tissue of gymnotus of a protein presenting several typical properties characteristic of the physiological receptor of acetylcholine].
    Changeux JP; Kasai M; Huchet M; Meunier JC
    C R Acad Hebd Seances Acad Sci D; 1970 Jun; 270(23):2864-7. PubMed ID: 4987937
    [No Abstract]   [Full Text] [Related]  

  • 11. The rate of action of competitive neuromuscular blocking agents.
    Waud DR
    J Pharmacol Exp Ther; 1967 Oct; 158(1):99-114. PubMed ID: 6054082
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical use of muscle relaxants.
    Foldes FF
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585
    [No Abstract]   [Full Text] [Related]  

  • 13. Muscle relaxants: advances in the last decade.
    Siker ES; Wolfson B; Schaner PJ
    Clin Anesth; 1969; 3():415-57. PubMed ID: 4330726
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of alpha-bungarotoxin and cholinergic ligands to acetylcholine receptors in the membrane of skeletal muscle.
    Barnard EA; Coates V; Dolly JO; Mallick B
    Cell Biol Int Rep; 1977 Jan; 1(1):99-106. PubMed ID: 610870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of hexafluorenium with other neuromuscular blocking agents in man.
    Foldes FF
    Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacokinetics of muscle relaxants.
    Wingard LB; Cook DR
    Clin Pharmacokinet; 1977; 2(5):330-43. PubMed ID: 913003
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromuscular blocking agents: structure and activity.
    Pauling P; Petcher TJ
    Chem Biol Interact; 1973 Jun; 6(6):351-65. PubMed ID: 4270640
    [No Abstract]   [Full Text] [Related]  

  • 18. A new kind of drug antagonism: evidence that agonists cause a molecular change in acetylcholine receptors.
    Rang HP; Ritter JM
    Mol Pharmacol; 1969 Jul; 5(4):394-411. PubMed ID: 5805474
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective enhancement of the interaction of curare with the nicotinic acetylcholine receptor.
    Filatov GN; Aylwin ML; White MM
    Mol Pharmacol; 1993 Aug; 44(2):237-41. PubMed ID: 8355663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle relaxants: the classical receptor theory.
    Willems J
    Acta Anaesthesiol Belg; 1976; 27(3):85-8. PubMed ID: 1032071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.